Ticker
AKBACompany Name
AKEBIA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Asset Turnover | Revenues |
---|---|---|---|
6/30/2025 | $ 345.6M | 0.59 | $ 203.73M |
3/31/2025 | $ 310.19M | 0.6 | $ 184.91M |
12/31/2024 | $ 220.67M | 0.73 | $ 160.18M |
9/30/2024 | $ 207.14M | 0.82 | $ 169.88M |
6/30/2024 | $ 220.2M | 0.79 | $ 174.5M |
3/31/2024 | $ 225.48M | 0.83 | $ 187.22M |
12/31/2023 | $ 241.7M | 0.81 | $ 194.62M |
9/30/2023 | $ 235M | 0.82 | $ 193.61M |
6/30/2023 | $ 253.71M | 0.79 | $ 200.53M |
3/31/2023 | $ 276.86M | 0.98 | $ 271.03M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Revenues / Assets
(=) Asset Turnover
Asset Turnover for AKEBIA THERAPEUTICS INC is calculated as follows: Revenues [ $ 308.16M ] / Assets [ $ 676.14M ]
(=) Asset Turnover [ 0.46 ]
Minimum
Sep 30, 2021
Maximum
Mar 31, 2023
Average
Median
filtered constituents | 4.17K |
---|---|
min | -0.79 |
max | 2.36 |
average | 0.53 |
median | 0.4 |
std | 0.52 |